Toru Tanaka
Tokyo, 1138603, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 139 publications
Aberrant expression of the PREX2-MAGI2 axis modulates myofibroblast differentiation in pulmonary fibrosis.
Journal: American journal of physiology. Lung cellular and molecular physiology
Published: August 22, 2026
Right Ventricular Isovolumetric Relaxation Time is Associated with Pulmonary Vascular Load and Functional Limitation in Chronic Obstructive Pulmonary Disease.
Journal: International journal of chronic obstructive pulmonary disease
Published: June 02, 2026
Mepolizumab initiation by day 30 and glucocorticoid exposure in newly diagnosed EGPA: a single-center 30-day landmark cohort study.
Journal: BMC pulmonary medicine
Published: May 10, 2026
Enhanced accumulation of protoporphyrin IX via SLC6A6 and SLC36A1 sensitizes cisplatin-resistant cells to 5-aminolevulinic acid-based photodynamic therapy.
Journal: Photodiagnosis and photodynamic therapy
Published: March 05, 2026
Pulmonary vascular resistance is associated with two-year clinical outcomes in non-hypoxemic COPD with mild pulmonary hemodynamic abnormalities.
Journal: Respiratory investigation
Published: March 02, 2026
Simultaneous Diffuse Alveolar Hemorrhage and Acute Myocarditis in an Immunocompetent Adult with a Human Metapneumovirus Infection.
Journal: Internal medicine (Tokyo, Japan)
Published: December 24, 2025
C-C Chemokine Receptor 4 Deficiency Protects Against Abdominal Aortic Aneurysm Formation.
Journal: Journal of the American Heart Association
Published: November 26, 2025
The role of the locus coeruleus in giant migrating contractions of colonic motility in Suncus murinus.
Journal: Experimental brain research
Published: November 24, 2025
284 nm UVB Phototherapy Regulates Immunoinflammatory Responses and Improves Atherosclerotic Plaque Stability in Mice.
Journal: The Kobe journal of medical sciences
Published: November 17, 2025
Low-dose vs standard-dose nintedanib at initiation in fibrosing interstitial lung disease: a target-trial emulation of treatment persistence and lung function.
Journal: Annals of the American Thoracic Society
Published: October 30, 2025
Drug-induced Interstitial Lung Disease with a Hypersensitivity Pneumonitis Pattern Following Pembrolizumab Plus Epirubicin and Cyclophosphamide Therapy: First Report with Pathological Findings.
Journal: Internal medicine (Tokyo, Japan)
Published: October 15, 2025
Screening for novel L-type amino acid transporter 1 (SLC7A5) inhibitors using a fluorescent amino acid.
Journal: Biochemical and biophysical research communications
Published: September 08, 2025
Last Updated: 09/26/2026